These gains stem from the sector’s ability to maintain growth momentum, supported by new product launches, stable generics ...

The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...

With the opening of classes in the country last month coinciding with the start of the rainy season, there is a higher risk ...

The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.

Nvidia has been the hottest stock since the start of the AI revolution, and I see one particular healthcare business ...

According to an IMS report (2011) the contribution of emerging markets to the growth of the pharmaceutical market has increased from 8% in 2003 to 40% in 2010. For example, in 2008 Chinese ...

The Drugs Controller General of India (DCGI) has declared as many as 16 commonly-used medicines as spurious, after they ...

Big Pharma corporate venture funds may operate ... in this sector where specialist knowledge is vital, capital to market very significant, and attrition rates high. Recently, there has been ...

Mutual Fund has introduced a new Manufacturing Fund, an open-ended equity scheme, aiming to capitalize on the growth ...

Going ahead, the positive move is likely to sustain in the benchmark indices despite underperfromance of broader markets. The ...

Dr. Reddy's Laboratories announced that the U.S. Food & Drug Administration (FDA) completed a routine Good Manufacturing Practice (GMP) inspection of its integrated product development organization in ...

© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.